Package | dk.kip.rkkp.fhir.ig.core |
Type | CodeSystem |
Id | ATC |
FHIR Version | R4 |
Source | https://kip.rkkp.dk/fhir/https://build.fhir.org/ig/KIP-infrastructure/implementation-guide/CodeSystem-ATC.html |
URL | https://kip.rkkp.dk/fhir/CodeSystem/ATC |
Version | 2.12.0 |
Status | active |
Date | 2022-06-14T00:00:00+02:00 |
Name | ATC |
Title | WHO ATC |
Description | WHO ATC code system. Link: http://www.whocc.no/atc |
Content | fragment |
ValueSet | |
ATCAntibiotikaprofylakseDKR | ATC - Antibiotikaprofylakse (DKR) |
ATCChemoCLL | ATC_CLL_kemo |
ATCChemoPreparation | ATC: Præparater for kemobehandling |
ATCDMPN | ATC DMPN |
ATCDMPN202410 | ATC DMPN 202410 |
ATCImmunotherapyCLL | ATC_CLL_immunterapi |
ATCTargetCLL | ATC_CLL_target |
ATCTromboseprofylakseDKR | ATC - Tromboseprofylakse (DKR) |
AntibiotikaprofylakseDHR | Antibiotikaprofylakse (DHR) |
AntibiotikaprofylakseDKRR | Antibiotikaprofylakse (DKRR) |
BehandlingCML | Behandling (CML) |
BehandlingCMMLMDS | Behandlinger foretaget i forbindelse med CMML (MDS) |
BehandlingMDS | Behandlinger foretaget i forbindelse med MDS (MDS) |
BehandlingsTypeStamcellestoetteLYFO | Behandlingsttype - Stamcellestøtte (LYFO) |
BloedningsprofylakseDHR | Blødningsprofylakse (DHR) |
Immunoterapi | Immunoterapi |
Kemoterapiregime | Kemoterapiregime |
Radioimmunoterapi | Radioimmunoterapi |
TreatmentPreservation | Vedligeholdelsesbehandling |
TreatmentScheduledDAMYDA | Planlagt behandling (DAMYDA) |
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: CodeSystem ATC
This case-sensitive code system https://kip.rkkp.dk/fhir/CodeSystem/ATC
provides a fragment that includes following codes in an undefined hierarchy:
{ "resourceType": "CodeSystem", "id": "ATC", "text": { "status": "generated", "div": "<!-- snip (see above) -->" }, "url": "https://kip.rkkp.dk/fhir/CodeSystem/ATC", "identifier": [ { "value": "urn:oid:2.16.840.1.113883.6.73" } ], "version": "2.12.0", "name": "ATC", "title": "WHO ATC", "status": "active", "date": "2022-06-14T00:00:00+02:00", "publisher": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S", "contact": [ { "name": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S", "telecom": [ { "system": "url", "value": "https://trifork.com" }, { "system": "email", "value": "rbk@trifork.com" } ] } ], "description": "WHO ATC code system. Link: http://www.whocc.no/atc", "caseSensitive": true, "content": "fragment", "concept": [ { "code": "B01A", "display": "ANTITHROMBOTIC AGENTS", "definition": "B01A - ANTITHROMBOTIC AGENTS", "concept": [ { "code": "B01AA03", "display": "warfarin", "definition": "B01AA03 - warfarin" }, { "code": "B01AB01", "display": "heparin", "definition": "B01AB01 - heparin" }, { "code": "B01AB04", "display": "dalteparin", "definition": "B01AB04 - dalteparin" }, { "code": "B01AB05", "display": "enoxaparin", "definition": "B01AB05 - enoxaparin" }, { "code": "B01AB10", "display": "tinzaparin", "definition": "B01AB10 - tinzaparin" }, { "code": "B01AC06", "display": "acetylsalicylic acid", "definition": "B01AC06 - acetylsalicylic acid" }, { "code": "B01AE07", "display": "dabigatran etexilate", "definition": "B01AE07 - dabigatran etexilate" }, { "code": "B01AF01", "display": "rivaroxaban", "definition": "B01AF01 - rivaroxaban" }, { "code": "B01AF02", "display": "apixaban", "definition": "B01AF02 - apixaban" }, { "code": "B01AX05", "display": "fondaparinux", "definition": "B01AX05 - fondaparinux" } ] }, { "code": "B02AA02", "display": "tranexamic acid", "definition": "B02AA02 - Tranexamic acid" }, { "code": "B03XA01", "display": "erythropoietin", "definition": "B03XA01 - erythropoietin" }, { "code": "C10AA", "display": "HMG CoA reductase inhibitors", "definition": "C10AA - HMG CoA reductase inhibitors" }, { "code": "H02", "display": "CORTICOSTEROIDS FOR SYSTEMIC USE", "definition": "H02 - CORTICOSTEROIDS FOR SYSTEMIC USE" }, { "code": "J01CF01", "display": "dicloxacillin", "definition": "J01CF01 - dicloxacillin" }, { "code": "J01CF02", "display": "cloxacillin", "definition": "J01CF02 - cloxacillin" }, { "code": "J01CF03", "display": "meticillin", "definition": "J01CF03 - meticillin" }, { "code": "J01CF05", "display": "flucloxacillin", "definition": "J01CF05 - flucloxacillin" }, { "code": "J01DB01", "display": "cefalexin", "definition": "J01DB01 - cefalexin" }, { "code": "J01DB03", "display": "cefalotin", "definition": "J01DB03 - cefalotin" }, { "code": "J01DC02", "display": "cefuroxime", "definition": "J01DC02 - cefuroxime" }, { "code": "J01FA01", "display": "erythromycin", "definition": "J01FA01 - erythromycin" }, { "code": "J01GB03", "display": "gentamicin", "definition": "J01GB03 - gentamicin" }, { "code": "J01XA01", "display": "vancomycin", "definition": "J01XA01 - vancomycin" }, { "code": "L01AA01", "display": "cyclophosphamide", "definition": "L01AA01 - cyclophosphamide" }, { "code": "L01AA02", "display": "chlorambucil", "definition": "L01AA02 - chlorambucil" }, { "code": "L01AA03", "display": "melphalan", "definition": "L01AA03 - melphalan" }, { "code": "L01AA06", "display": "ifosfamide", "definition": "L01AA06 - ifosfamide" }, { "code": "L01AA09", "display": "bendamustine", "definition": "L01AA09 - bendamustine" }, { "code": "L01AB01", "display": "busulfan", "definition": "L01AB01 - busulfan" }, { "code": "L01AC01", "display": "thiotepa", "definition": "L01AC01 thiotepa" }, { "code": "L01AD01", "display": "carmustine", "definition": "L01AD01 - carmustine" }, { "code": "L01AX03", "display": "temozolomide", "definition": "L01AX03 - temozolomide" }, { "code": "L01AX04", "display": "dacarbazine", "definition": "L01AX04 - dacarbazine" }, { "code": "L01BB05", "display": "fludarabine", "definition": "L01BB05 - fludarabine" }, { "code": "L01BC02", "display": "fluorouracil", "definition": "L01BC02 - Fluorouracil (5-FU)" }, { "code": "L01BC05", "display": "gemcitabine", "definition": "L01BC02 - Gemcitabine" }, { "code": "L01BC06", "display": "capecitabine", "definition": "L01BC06 - Capecitabine" }, { "code": "L01BC07", "display": "azacitidine", "definition": "L01BC07 - azacitidine" }, { "code": "L01CA02", "display": "vincristine", "definition": "L01CA02 - vincristine" }, { "code": "L01CA04", "display": "vinorelbine", "definition": "L01CA04 - Vinorelbine" }, { "code": "L01CB01", "display": "etoposide", "definition": "L01CB01 - etoposide" }, { "code": "L01CD01", "display": "paclitaxel", "definition": "L01CD01 - Paclitaxel" }, { "code": "L01CD02", "display": "docetaxel", "definition": "L01CD02 - Docetaxel" }, { "code": "L01CE02", "display": "irinotecan", "definition": "L01CE02 - Irinotecan" }, { "code": "L01DB01", "display": "doxorubicin", "definition": "L01DB01 - Doxorubicin" }, { "code": "L01DB03", "display": "epirubicin", "definition": "L01DB03 - Epirubicin" }, { "code": "L01DB07", "display": "mitoxantrone", "definition": "L01DB07 - mitoxantrone" }, { "code": "L01DB11", "display": "pixantrone", "definition": "L01DB11 - pixantrone" }, { "code": "L01DC01", "display": "bleomycin", "definition": "L01DC01 - bleomycin" }, { "code": "L01EA", "display": "BCR-ABL tyrosine kinase inhibitors", "concept": [ { "code": "L01EA01", "display": "imatinib", "definition": "L01EA01 - imatinib" }, { "code": "L01EA02", "display": "dasatinib", "definition": "L01EA02 - dasatinib" }, { "code": "L01EA03", "display": "nilotinib", "definition": "L01EA03 - nilotinib" }, { "code": "L01EA04", "display": "bosutinib", "definition": "L01EA04 - bosutinib" }, { "code": "L01EA05", "display": "ponatinib", "definition": "L01EA05 - ponatinib" }, { "code": "L01EA06", "display": "Asciminib", "definition": "L01EA06 - Asciminib" } ] }, { "code": "L01EB", "display": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors", "definition": "L01EB - Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors" }, { "code": "L01EH", "display": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors", "definition": "L01EH - Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors" }, { "code": "L01EJ", "display": "Janus-associated kinase (JAK) inhibitors", "definition": "Janus associerede kinase (JAK) hæmmere", "concept": [ { "code": "L01EJ01", "display": "ruxolitinib", "definition": "L01EJ01 - ruxolitinib" } ] }, { "code": "L01EK", "display": "Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors", "definition": "L01EK - Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors" }, { "code": "L01EL01", "display": "ibrutinib", "definition": "L01EL01 - ibrutinib" }, { "code": "L01EL02", "display": "acalabrutinib", "definition": "L01EL02 - acalabrutinib" }, { "code": "L01EM01", "display": "idelalisib", "definition": "L01EM01 - idelalisib" }, { "code": "L01EN", "display": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors", "definition": "L01EN - Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors" }, { "code": "L01FA01", "display": "rituximab", "definition": "L01FA01 - rituximab" }, { "code": "L01FA02", "display": "ofatumumab", "definition": "L01FA02 - ofatumumab" }, { "code": "L01FA03", "display": "obinutuzumab", "definition": "L01FA03 - obinutuzumab" }, { "code": "L01FC01", "display": "daratumumab", "definition": "L01FC01 - daratumumab" }, { "code": "L01FC02", "display": "isatuximab", "definition": "L01FC02 - isatuximab" }, { "code": "L01FD01", "display": "trastuzumab", "definition": "L01FD01 - Trastuzumab" }, { "code": "L01FF", "display": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors", "definition": "L01FF - PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors", "concept": [ { "code": "L01FF01", "display": "nivolumab", "definition": "L01FF01 - Nivolumab" }, { "code": "L01FF02", "display": "pembrolizumab", "definition": "L01FF02 - Pembrolizumab" } ] }, { "code": "L01FG01", "display": "bevacizumab", "definition": "L01FG01 - Bevacizumab" }, { "code": "L01FX05", "display": "brentuximab vedotin", "definition": "L01FX05 - brentuximab vedotin" }, { "code": "L01FX08", "display": "elotuzumab", "definition": "L01FX08 - elotuzumab" }, { "code": "L01FX14", "display": "polatuzumab vedotin", "definition": "L01FX14 - polatuzumab vedotin" }, { "code": "L01XA01", "display": "cisplatin", "definition": "L01XA01 - Cisplatin" }, { "code": "L01XA02", "display": "carboplatin", "definition": "L01XA02 - Carboplatin" }, { "code": "L01XA03", "display": "oxaliplatin", "definition": "L01XA03 - Oxaliplatin" }, { "code": "L01XG01", "display": "bortezomib", "definition": "L01XG01 - bortezomib" }, { "code": "L01XG02", "display": "carfilzomib", "definition": "L01XG02 - carfilzomib" }, { "code": "L01XG03", "display": "ixazomib", "definition": "L01XG03 - ixazomib" }, { "code": "L01XH", "display": "Histone deacetylase (HDAC) inhibitors", "definition": "L01XH - Histone deacetylase (HDAC) inhibitors", "concept": [ { "code": "L01XH01", "display": "vorinostat", "definition": "L01XH01 - vorinostat" }, { "code": "L01XH03", "display": "panobinostat", "definition": "L01XH03 - panobinostat" } ] }, { "code": "L01XX05", "display": "hydroxycarbamide", "definition": "L01XX05 - hydroxycarbamide" }, { "code": "L01XX35", "display": "anagrelide", "definition": "L01XX35 - anagrelide" }, { "code": "L01XX52", "display": "venetoclax", "definition": "L01XX52 - venetoclax" }, { "code": "L03AB", "display": "Interferons", "definition": "L03AB - Interferons" }, { "code": "L04A", "display": "IMMUNOSUPPRESSANTS", "definition": "L04A - IMMUNOSUPPRESSANTS", "concept": [ { "code": "L04AA", "display": "Selective immunosuppressants", "definition": "L04AA - Selective immunosuppressants", "concept": [ { "code": "L04AA34", "display": "alemtuzumab", "definition": "L04AA34 - alemtuzumab" }, { "code": "L04AA40", "display": "cladribine", "definition": "L04AA40 - cladribine" } ] } ] }, { "code": "L04AD01", "display": "ciclosporin", "definition": "L04AD01 - ciclosporin" }, { "code": "L04AX02", "display": "thalidomide", "definition": "L04AX02 - thalidomide" }, { "code": "L04AX04", "display": "lenalidomide", "definition": "L04AX04 - lenalidomide" }, { "code": "L04AX06", "display": "pomalidomide", "definition": "L04AX06 - pomalidomide" }, { "code": "M05BA03", "display": "pamidronic acid", "definition": "M05BA03 - pamidronic acid" }, { "code": "M05BA08", "display": "zoledronic acid", "definition": "M05BA08 - zoledronic acid" }, { "code": "M05BX04", "display": "denosumab", "definition": "M05BX04 - denosumab" }, { "code": "S01LA08", "display": "bevacizumab", "definition": "S01LA08 - Bevacizumab" }, { "code": "V10X", "display": "OTHER THERAPEUTIC RADIOPHARMACEUTICALS", "definition": "V10X - OTHER THERAPEUTIC RADIOPHARMACEUTICALS", "concept": [ { "code": "V10XA53", "display": "tositumomab/iodine (131I) tositumomab", "definition": "V10XA53 - tositumomab/iodine (131I) tositumomab" }, { "code": "V10XX02", "display": "ibritumomab tiuxetan (90Y)", "definition": "V10XX02 - ibritumomab tiuxetan (90Y)" } ] } ] }